Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Tuesday, 1st October 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380 060 which commenced at 5:00 P.M. and concluded at 6:00 P.M., inter-alia has considered and approved: 1. Appointment of Ms. Aesha Harsh Shah (DIN: 10423365) as Additional Non-Executive Independent Director of the Company w.e.f 1st October, 2024. 2. Resignation of Mr. Pranav Manoj Vajani (DIN: 09213749) from Independent Director of the Company w.e.f 1st October, 2024. 3. Reconstitution of the Audit Committee of the Company w.e.f. 1st October, 2024 4. Reconstitution of the Nomination and Remuneration Committee of the Company w.e.f. 1st October, 2024

pdf

Evoq Remedies Ltd.

01 Oct 2024

4.76

-1.86%

AGM

Evoq Remedies Ltd - 543500 - Submission Of Voting Result Of The Annual General Meeting

BSE India

Submission of Annual General Meeting of the Company

pdf

Evoq Remedies Ltd.

01 Oct 2024

4.76

-1.86%

AGM

Evoq Remedies Ltd - 543500 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Submission of Scrutinizer report of the Company

pdf

Evoq Remedies Ltd.

30 Sep 2024

4.76

-1.86%

SAST

Evoq Remedies Ltd - 543500 - Closure of Trading Window

BSE India

Intimation of Trading window closure

pdf

Evoq Remedies Ltd.

28 Sep 2024

4.76

-1.86%

AGM

Evoq Remedies Ltd - 543500 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Outcome and Summary of 14th Annual General Meeting of the Company held today i.e. 28th September 2024

pdf

Evoq Remedies Ltd.

06 Sep 2024

4.76

-1.86%

AGM

Evoq Remedies Ltd - 543500 - Submission Of Annual Report For Financial Year 2023-24

BSE India

Submission of Annual Report f.y. 2023-24

pdf

Evoq Remedies Ltd.

06 Sep 2024

4.76

-1.86%

Corp. Note

Evoq Remedies Ltd - 543500 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the 14th Annual General Meeting of the Company to be held on Saturday, 28th September at 12:30 A.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) at the Registered Office of the Company.

pdf

VOTE: Is Evoq Remedies Ltd. worth buying?

12 Votes:

Buy 91.67%

Sell 8.33%